Khiron Life Sciences Corp.
KHRNF · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9 | $22 | $9 | $15 |
| Short-Term Investments | $0 | $0 | $28 | $4 |
| Receivables | $3 | $5 | $4 | $3 |
| Inventory | $9 | $8 | $1 | $0 |
| Other Curr. Assets | $3 | $2 | $3 | $2 |
| Total Curr. Assets | $24 | $36 | $45 | $24 |
| Property Plant & Equip (Net) | $14 | $18 | $16 | $10 |
| Goodwill | $4 | $4 | $4 | $5 |
| Intangibles | $1 | $15 | $16 | $2 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $1 | $0 |
| Total NC Assets | $19 | $37 | $37 | $16 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $42 | $73 | $82 | $40 |
| Liabilities | – | – | – | – |
| Payables | $4 | $6 | $7 | $6 |
| Short-Term Debt | $2 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | -$0 | $0 |
| Other Curr. Liab. | $2 | $0 | $1 | $0 |
| Total Curr. Liab. | $8 | $7 | $8 | $7 |
| LT Debt | $1 | $0 | $0 | $1 |
| Deferred Rev, NC | $0 | $0 | -$1 | $3 |
| Deferred Tax Liab, NC | $0 | $1 | $1 | $1 |
| Other NC Liab. | $1 | $2 | $3 | $4 |
| Total NC Liab. | $1 | $3 | $3 | $8 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $0 | $0 |
| Total Liabilities | $9 | $10 | $12 | $15 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $146 | $137 | $121 | $40 |
| Retained Earnings | -$117 | -$84 | -$60 | -$24 |
| AOCI | $4 | $10 | $9 | -$0 |
| Other Equity | $0 | $0 | $0 | $10 |
| Total Equity | $33 | $63 | $70 | $26 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $42 | $73 | $82 | $40 |
| Net Debt | -$7 | -$21 | -$9 | -$14 |